Theraclone Sciences's competitors

Theraclone Sciences's competitors include ProtoKinetix, Parexel International, Oxford Nanopore Technologies and Fate Therapeutics
Add company...
Theraclone Sciences
A privately-held biotechnology company focused on developing novel tumor- specific therapeutic antibodies for the treatment of cancer and infectious disease.
ProtoKinetix
ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.
Parexel International
Parexel International is a biopharmaceutical outsourcing services company.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA and proteins.
Fate Therapeutics
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Founding Date
Founding Date
2004
Founding Date
1999
Founding Date
1983
Founding Date
2005
Founding Date
2007
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Saint Marys, US HQ
Locations
Waltham, US HQ
Vicente López, AR
Macquarie Park, AU
Wavre, BE
Centro, BR
Chaoyang Qu, CN
Pudong Xinqu, CN
see more
Locations
Oxford, GB HQ
Locations
San Diego, US HQ
Employees
Employees
12
Employees
N/A
Employees
18,900 2% increase
Employees
270 2% increase
Employees
66
Valuation ($)
Valuation ($)
N/A
Valuation ($)
15.3 m
Valuation ($)
4.6 b
Valuation ($)
1.6 b
Valuation ($)
362.9 m
Facebook followers
Facebook followers
N/A
Facebook followers
N/A
Facebook followers
4.7 k
Facebook followers
1.6 k
Facebook followers
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
97
Twitter followers
8.1 k
Twitter followers
21.7 k
Twitter followers
853

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.4b (FY, 2016)
Revenue (est.)
£4.5m (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
N/A
Net income
$154.9m (FY, 2016)
Net income
(£59.1m) (FY, 2016)
Net income
($33.5m) (FY, 2016)

Funding

Latest funding round
Latest funding round
$ 3.1m (almost 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 126m (about 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 58.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 625.1m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles